March 01, 2011 Archives - Clinical Advisor

Print Issue: March 01, 2011

Safyral is engineered to reduce the risks of rare neural tube defects.

Contraceptive to raise folate levels

Combination oral contraceptives reduce the risk of pregnancy primarily by inhibiting ovulation. This product combines drospirenone, an analogue of spironolactone that has both antimineralocorticoid and antiandrogenic activities, with an estrogen-plus-folate supplementation.

Kapvay is indicated for use as add-on therapy to stimulate medications.

Extended-release tab for ADHD

This formulation of clonidine is indicated for treating patients with ADHD, either as monotherapy or as adjunctive therapy to stimulant medications. It has not been studied in adults.

Next post in Clinical Pearls